Skip to main content
Erschienen in: Molecular and Cellular Pediatrics 1/2016

Open Access 01.12.2016 | Editorial

Molecular biology of the gut

verfasst von: Hassan Y. Naim, Klaus-Peter Zimmer, Buford Nichols

Erschienen in: Molecular and Cellular Pediatrics | Ausgabe 1/2016

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Editorial

The gastrointestinal tract is the largest exposed surface among mammalian macroorganisms. It is constantly exposed to substantial challenges and exerts a potpourri of diverse physiological functions. Among the major intestinal functions is the digestion of nutrients and subsequent uptake and metabolism of their respective building blocks, control of absorption and secretion of water, salts and nutrients, interaction of the mucosal surface with micro-organisms and cross-talk with the submucosa, and communication at the basolateral surface with cells of innate and adaptive immune system. These functions are tightly linked to a large network of protein and lipid components that exert their function at different stages of intestinal development and differentiation of intestinal cells. Obviously, genetic alterations linking these vital networks elicit malfunctions that are associated with severe disease phenotypes.
On September 4 and 5, 2016, a workshop on the molecular biology of the gut was held during the Congress of the German Society for Pediatric and Adolescent Medicine (DGKJ) in Munich and was generously sponsored by QOL Medical LLC, Vero Beach, FL, USA. This was a multidisciplinary workshop that combined molecular, cellular, immunological, and microbiological aspects of the gastrointestinal tract with clinical medicine and nutritional science. Experts viewed the gut as an organ from different angles and presented timely and comprehensive reviews on the impact of intestinal cellular and protein components and the corresponding basic mechanisms that maintain the functional capacities and the physiological hemostasis of the gut. The digestive function in the intestine, for example, is one of the most important and essential processes that are orchestrated by an organized and regulated network of hydrolases and transporters that are located in the microvillus membrane. Unraveling of the structural-functional relationships of these components as well as their biosynthetic and processing pathways has experienced a huge progress in the last few years, so that their malfunctioning and association with the onset of intestinal disorders and symptoms can be clarified. Particularly, the cell biology and pathobiochemistry of intestinal disaccharidases has occupied a major part of this workshop by virtue of the primordial function of the sucrase-isomaltase enzyme complex in carbohydrate and human starch digestion to glucose (α-glucogenesis) [1]. Sucrase-isomaltase is the major brush border enzyme with almost 5–7 % protein content of the entire brush border membrane and is the enzyme that is responsible for the digestion of almost all disaccharides that are transported to the intestinal lumen [2]. The expression of this protein during cellular differentiation as well as primary and secondary deficiencies has been among the topics discussed in this workshop [3]. Particularly, recent progress in identification of a large number of mutations associated with primary genetically determined sucrase-isomaltase deficiency (GSID or CSID) as well as various inheritance forms of this disorder has strongly suggested that this disorder is more common than initially thought. The implications of studying GSID is an important step towards developing therapies and envision approaches to botanical and technological alterations in food that will benefit all populations. Interestingly, the pathogenesis and the basic mechanisms that account for irritable bowel syndrome (IBS), one of the most common intestinal diseases, are until present obscure [4, 5]. Current concepts assume that aberrant or reduced functional capacities of intestinal disaccharidases, such as sucrase-isomaltase, are likely to be linked to the symptoms of IBS.
Not only is aberrant function of intestinal disaccharidases associated with chronic diarrhea, but also fructose malabsorption and insufficiencies in glucose transporters or NHE3 [6]. The workshop has also discussed the more global defects at the cellular levels such as in celiac disease, microvillus inclusion disease, or cystic fibrosis which also elicit chronic diarrhea [79]. Altogether, these disorders lead to substantial alterations of the intestinal microbiota and may alter and disturb the finely tuned intestinal hemostasis [10]. In fact, the gut mucosa is continuously exposed to bacterial and dietary antigens found in the lumen and microbial infections can stress and regulate the epithelial cell integrity and physiology.
The intestine brandishes a low-grade physiological inflammation, whereby the enterocytes and intraepithelial lymphocytes are essential in maintaining the gut hemostasis, since they constitute the first line of defense against pathogens and toxic molecules such as gliadin [8]. Under pathological conditions, such as the inflammatory bowel disease (IBD), the intestinal mucosa is infiltrated by inflammatory cells including neutrophils, macrophages, and lymphocytes. Here, the workshop covered the molecular genetics of IBD, the interaction between epithelial cells and lymphocytes, and addressed the question towards the regulation of enterocyte metabolism and proliferation by hypoxia-induced factors and stress [11, 12].
The presentations at the workshop were published in the peer-reviewed open-access journal Molecular and Cellular Pediatrics and are compiled in a printed version as a special issue. We are grateful to our colleagues for their outstanding contributions to the success of the workshop and for the excellent chapters in this book. We thank the German Society for Pediatric and Adolescent Medicine (DGKJ) for the financial support of this special issue.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Nichols BL, Diaz-Sotomayor M, Avery SE, Chacko SK, Hadsell DL, Baker SS et al. (2016) Milk glucosidase activity enables suckled pup starch digestion. Mol Cell Pediatr 3(1):4, Pubmed Central PMCID: 4735098CrossRefPubMedPubMedCentral Nichols BL, Diaz-Sotomayor M, Avery SE, Chacko SK, Hadsell DL, Baker SS et al. (2016) Milk glucosidase activity enables suckled pup starch digestion. Mol Cell Pediatr 3(1):4, Pubmed Central PMCID: 4735098CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Gericke B, Amiri M, Naim HY (2016) The multiple roles of sucrase-isomaltase in the intestinal physiology. Mol Cell Pediatr 3(1):2, Pubmed Central PMCID: 4728165CrossRefPubMedPubMedCentral Gericke B, Amiri M, Naim HY (2016) The multiple roles of sucrase-isomaltase in the intestinal physiology. Mol Cell Pediatr 3(1):2, Pubmed Central PMCID: 4728165CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Chumpitazi BP, Shulman RJ (2016) Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome. Mol Cell Pediatr 3(1):11, Pubmed Central PMCID: 4755958CrossRefPubMedPubMedCentral Chumpitazi BP, Shulman RJ (2016) Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome. Mol Cell Pediatr 3(1):11, Pubmed Central PMCID: 4755958CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Vogel GF, Hess MW, Pfaller K, Huber LA, Janecke AR, Muller T (2016) Towards understanding microvillus inclusion disease. Mol Cell Pediatr 3(1):3, Pubmed Central PMCID: 4733813CrossRefPubMedPubMedCentral Vogel GF, Hess MW, Pfaller K, Huber LA, Janecke AR, Muller T (2016) Towards understanding microvillus inclusion disease. Mol Cell Pediatr 3(1):3, Pubmed Central PMCID: 4733813CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Esposito S, Tosco A, Villella VR, Raia V, Kroemer G, Maiuri L (2016) Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis. Mol Cell Pediatr 3(1):13, Pubmed Central PMCID: 4791443CrossRefPubMedPubMedCentral Esposito S, Tosco A, Villella VR, Raia V, Kroemer G, Maiuri L (2016) Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis. Mol Cell Pediatr 3(1):13, Pubmed Central PMCID: 4791443CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Pillich H, Loose M, Zimmer KP, Chakraborty T (2016) Diverse roles of endoplasmic reticulum stress sensors in bacterial infection. Mol Cell Pediatr 3(1):9, Pubmed Central PMCID: 4755955CrossRefPubMedPubMedCentral Pillich H, Loose M, Zimmer KP, Chakraborty T (2016) Diverse roles of endoplasmic reticulum stress sensors in bacterial infection. Mol Cell Pediatr 3(1):9, Pubmed Central PMCID: 4755955CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Zeitouni NE, Chotikatum S, von Köckritz-Blickwede M, Naim HY (2016) The impact of hypoxia on intestinal epithelial cell functions: consequences for invasion by bacterial pathogens. Mol Cell Pediatr 3(1):14, Pubmed Central PMCID: 4803720CrossRefPubMedPubMedCentral Zeitouni NE, Chotikatum S, von Köckritz-Blickwede M, Naim HY (2016) The impact of hypoxia on intestinal epithelial cell functions: consequences for invasion by bacterial pathogens. Mol Cell Pediatr 3(1):14, Pubmed Central PMCID: 4803720CrossRefPubMedPubMedCentral
Metadaten
Titel
Molecular biology of the gut
verfasst von
Hassan Y. Naim
Klaus-Peter Zimmer
Buford Nichols
Publikationsdatum
01.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Molecular and Cellular Pediatrics / Ausgabe 1/2016
Elektronische ISSN: 2194-7791
DOI
https://doi.org/10.1186/s40348-016-0059-1

Weitere Artikel der Ausgabe 1/2016

Molecular and Cellular Pediatrics 1/2016 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.